Inventor
MAH ROBERT
CH48 patents
⚠️ This page may combine multiple inventors who share the name “MAH ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
22 patentsUS7795253B2Sep 14, 2010
Condensed imidazole derivatives as aromatase inhibitors
NOVARTIS AG8 citations84
US8815926B2Aug 26, 2014
Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
NOVARTIS AG8 citations83
US7799780B2Sep 21, 2010
Condensed imidazole derivatives as aldosterone synthase inhibitors
NOVARTIS AG11 citations83
US5719141AFeb 17, 1998
2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives
NOVARTIS AG18 citations82
US6319917B1Nov 20, 2001
Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
NOVARTIS AG14 citations72
US5929067AJul 27, 1999
1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
NOVARTIS AG9 citations72
US10130629B2Nov 20, 2018
Pharmaceutical combinations
NOVARTIS AG3 citations71
US7879847B2Feb 1, 2011
Imidazo compounds
NOVARTIS AG4 citations62
US7790715B2Sep 7, 2010
Organic compounds
NOVARTIS AG3 citations62
US10786492B2Sep 29, 2020
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations51
US9556180B2Jan 31, 2017
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
NOVARTIS AG1 citations51
US8022069B2Sep 20, 2011
Substituted piperidines as renin inhibitors
NOVARTIS AG0 citations51
US8008334B2Aug 30, 2011
Bis-heterocyclic imidazolyl compounds
NOVARTIS AG0 citations51
US10507201B2Dec 17, 2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations49
US11702409B2Jul 18, 2023
Pyrazolyl derivatives useful as anti-cancer agents
NOVARTIS AG0 citations47
US8357707B2Jan 22, 2013
2-carboxamide cycloamino ureas
NOVARTIS AG0 citations41
US8022068B2Sep 20, 2011
Substituted piperidines as renin inhibitors
NOVARTIS AG0 citations41
US8003640B2Aug 23, 2011
Organic compounds
NOVARTIS AG0 citations41
US7868036B2Jan 11, 2011
Organic compounds
NOVARTIS AG0 citations40
US7851634B2Dec 14, 2010
5-amino 4-hydroxy-7-(1H-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
NOVARTIS AG0 citations40
US7799779B2Sep 21, 2010
Substituted piperidines as renin inhibitors
NOVARTIS AG0 citations40
US7723550B2May 25, 2010
Process for preparing organic compounds
NOVARTIS AG0 citations40
HEROLD PETER
10 patentsUS8071773B2Dec 6, 2011
Heterocyclic spiro-compounds as aldosterone synthase inhibitors
HEROLD PETER9 citations82
US8076327B2Dec 13, 2011
Condensed imidazole derivatives as aldosterone synthase inhibitors
HEROLD PETER2 citations61
US8680079B2Mar 25, 2014
Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibitors
HEROLD PETER1 citations51
US8263615B2Sep 11, 2012
Bis-heterocyclic imidazolyl compounds
HEROLD PETER0 citations51
US8138176B2Mar 20, 2012
Imidazo compounds
HEROLD PETER0 citations51
US8138179B2Mar 20, 2012
Spiro-imidazo compounds
HEROLD PETER0 citations40
US8071774B2Dec 6, 2011
Heterocyclic spiro-compounds as aldosterone synthase inhibitors
HEROLD PETER0 citations40
US8071651B2Dec 6, 2011
5-amino-4-hydroxy-7-(imidazo [1,2-A] pyridin-6-ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
HEROLD PETER0 citations40
US8058307B2Nov 15, 2011
Alcanoic acid amides substituted by saturated O-heterocycles
HEROLD PETER0 citations40
US8324235B2Dec 4, 2012
Heterocyclic spiro-compounds
HEROLD PETER0 citations39
BUSCHMANN NICOLE
5 patentsUS9266883B2Feb 23, 2016
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE16 citations90
US9533988B2Jan 3, 2017
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE13 citations82
US9896449B2Feb 20, 2018
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE2 citations71
US9802917B2Oct 31, 2017
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
BUSCHMANN NICOLE2 citations70
US10189813B2Jan 29, 2019
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE0 citations51
SPEEDEL EXPERIMENTA AG
4 patentsUS7612088B2Nov 3, 2009
Heterocyclic compounds and their use as aldosterone synthase inhibitors
SPEEDEL EXPERIMENTA AG7 citations72
US7615664B2Nov 10, 2009
Phenyloctanamides
SPEEDEL EXPERIMENTA AG5 citations61
US7625893B2Dec 1, 2009
Substituted 4-phenyl piperidines for use as renin inhibitors
SPEEDEL EXPERIMENTA AG3 citations60
US7687495B2Mar 30, 2010
Substituted piperidines
SPEEDEL EXPERIMENTA AG1 citations47